Monday, April 01, 2019
05:42PM / NSE
The Board of Directors and Management of Presco Plc hereby advises its esteemed shareholders and other stakeholders that it was unable to submit its 2018 audited financial statements to The Nigerian Stock Exchange (NSE) and the Securities and Exchange Commission within the time frame required by the regulatory agencies.
This was not anticipated as the Company has expected to finalize and publish its 2018 audited financial statements on /or before March 31, 2019. The delay is as a result of issues relating to biological assets valuation. The biological assets valuation experts engaged to value our biological assets have not concluded the peer review of the valuation. Consequently, Presco Plc require a couple of weeks to finalize all actions required to sign off on the biological assets valuation as at December 31, 2018. The expected filing date is on or before April 30, 2019 but not later than April 30, 2019.
This publication can also be found on the company’s Website: www.presco-plc.com
2. Presco Q2 2018 Results Review: Maintaining Neutral Rating